CYP cynata therapeutics limited

warf licence

  1. 1,141 Posts.
    lightbulb Created with Sketch. 218
    The eureka report may 2018..kohler.

    Ross refers to not jeopardising the licence as a result of lack of performance.
    This was at a time when potential near term revenue was 2019..2020..japan aGVHD..
    Whilst the Front page Nature article is a powerful testament to Cymerus, it also acts as an advertising board to venture capitalists/ entrepreneurs who may be looking to take over the WARF licence as a result of performance failure after 9 yrs.
    As a result of investor concern re the termination clauses based on Ross,s Eureka report comments I asked for a copy of the WARF licence...I was refused on the basis of confidentiality..fair enough.
    But for me now time has all but run out...Fuji voluntary escrow period will be the times up limit.
    Maybe they should add more members to the board who join without first having bought a single share.
    job well done board, i wonder how they will divvy up.the 20 odd million if a termination clause is triggered.
    Quite incredible...ha!!
    Try asking for a cooy of the licence..see where it gets you?
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
15.0¢
Change
-0.020(11.8%)
Mkt cap ! $33.89M
Open High Low Value Volume
17.0¢ 18.0¢ 15.0¢ $101.9K 619.3K

Buyers (Bids)

No. Vol. Price($)
7 153571 15.0¢
 

Sellers (Offers)

Price($) Vol. No.
15.5¢ 12550 1
View Market Depth
Last trade - 16.10pm 30/06/2025 (20 minute delay) ?
CYP (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.